Emerging-market stocks fell, trimming the biggest monthly rally in 20 months, as OAO Sberbank led declines in Russia and Indian lenders retreated on concern the central bank will tighten monetary-policy further.
The MSCI Emerging Markets Index dropped 0.3 percent to 999.88, extending its weekly retreat to 1.3 percent. Sberbank slumped 2.9 percent amid bets Russia�� biggest lender will need additional capital to pay dividends at the level sought by government. ICICI Bank Ltd. (ICICIBC) decreased 2.4 percent in Mumbai. The Borsa Istanbul National 100 Index fell for a sixth day. South Africa�� rand capped the longest slide in almost two months.
Sberbank would need to boost capital to pay 35 percent of income in dividends and lending would slow if such a rule was set, Interfax and RIA Novosti cited Chief Executive Officer Herman Gref as saying. India�� central bank will add to last week�� surprise rate increase, seven of 10 analysts said in a Bloomberg News survey. Mounting concern that a political impasse over the U.S. federal budget will hurt the world�� largest economy also drove emerging-market equities lower.
Best Semiconductor Companies To Invest In 2015: Dollar Tree Inc.(DLTR)
Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.
Advisors' Opinion:- [By Dan Moskowitz]
The shiniest dollar
Many investors and analysts like to debate which dollar store offers the best investment opportunity. The truth is that Dollar General, Dollar Tree Stores (NASDAQ: DLTR ) , and Family Dollar Stores (NYSE: FDO ) are all likely to be quality long-term investments. - [By Ethan Roberts]
Shares of Dollar Tree (DLTR) were substantially lower this morning after the company reported third-quarter earnings. Dollar Tree earnings tallied 59 cents per diluted share of DLTR stock, which missed analyst estimates by two pennies.
10 Best Heal Care Stocks To Buy Right Now: Daily Mail and General Trust PLC (DMGT)
Daily Mail and General Trust PLC (DMGT) is a United kingdom-based multi-media and information company. The Company�� business activities are split into seven operating segments: RMS, business information, events, Euromoney, national media, local media and radio. Its dmg information is a business information division, providing business to business (B2B) information to the property, financial, energy and educational recruitment markets. As of October 2, 2011, dmg events, its business-to-business (B2B) exhibition and conferences division, operated 27 exhibitions and two conference businesses. Euromoney Institutional Investor PLC is a B2B media group. Associated Newspapers is its newspaper division. In September 2012, it sold its remaining 50% interest in DMG Radio Australia to Illyria. In July 2013, Daily Mail and General Trust PLC announced that Rothermere Continuation Limited has a holding 89.2% of interest of the Company. Advisors' Opinion:- [By Inyoung Hwang]
Daily Mail & General Trust Plc (DMGT) climbed 2.4 percent to 861 pence. The company said contribution from national newspapers to the group�� revenue dropped to 36 percent this year from 43 percent in 2012 and will fall further. The publisher of Britain�� second-biggest U.K. daily newspaper forecast full-year revenue will be 1.8 billion pounds, matching analysts�� estimates.
10 Best Heal Care Stocks To Buy Right Now: Sirius XM Radio Inc.(SIRI)
Sirius XM Radio Inc. provides satellite radio services in the United States and Canada. It broadcasts a programming lineup of approximately 135 channels of commercial-free music, sports, news and information, talk and entertainment, traffic, and weather on subscription fee basis through two satellite radio systems in the United States; and holds an interest in the satellite radio services offered in Canada. The company also simulcasts music and selected non-music channels over the Internet; and offers applications to allow consumers to access its Internet services on mobile devices. As of December 31, 2010, it had 20,190,964 subscribers. In addition, the company designs, establishes specifications, sources or specifies parts and components, and manages various aspects of the logistics and production of satellite radios; licenses its technology to various electronics manufacturers to develop, manufacture, and distribute radios under various brands; and imports radios distri buted through its Websites. The company?s satellite radios are primarily distributed through automakers, retailers, and its Websites. Further, it provides music services for commercial establishments; a satellite television service to offer music channels as part of certain programming packages on the DISH Network satellite television service; music and comedy channels to mobile phone users through mobile phone carriers; Backseat TV, a service offering television content designed primarily for children in the backseat of vehicles; Travel Link, a suite of data services that include graphical weather, fuel prices, sports schedules and scores, and movie listings; and real-time traffic and weather services. The company was formerly known as Sirius Satellite Radio Inc. and changed its name to Sirius XM Radio Inc. in August 2008. Sirius XM Radio Inc. was founded in 1990 and is headquartered in New York, New York.
Advisors' Opinion:- [By Blake Bos]
The Internet radio debate continues to heat up with the news that�Apple� (NASDAQ: AAPL ) is prepping to go prime time in the space. Shares in �Pandora� (NYSE: P ) and�Sirius XM� (NASDAQ: SIRI ) �took a licking in trading on the announcement -- but investors should keep an eye on the real story.�While the media would have you believe there can be only one victor in the battle for radio supremacy between Apple, Sirius XM,�Pandora, and many more, Motley Fool analyst Blake Bos has a different viewpoint worth considering.
- [By Paul Ausick]
At the very least, to dislodge the YouTube giant will require a massive investment in popular talent. Katie Couric�� addition to Yahoo�� stable was a start, but the company is going to need to do a deal with someone like Howard Stern at an enormous contract rate. Stern got $500 million from Sirius XM Holdings Inc. (NASDAQ: SIRI) in his original five-year deal and a similar deal for the next five years through the end of 2015. �Stern will be available relatively soon, but he won�� come cheap. Just sayin��
10 Best Heal Care Stocks To Buy Right Now: Spectrum Pharmaceuticals Inc.(SPPI)
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company, primarily focuses on oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. It markets Zevalin, a prescribed form of cancer therapy, radioimmunotherapy; and Fusilev, a novel folate analog formulation and the pharmacologically active isomer of the racemic compound, calcium leucovorin. The company?s drugs in late stage development include Apaziquone, an anti-cancer agent; and Belinostat, a histone deacytelase inhibitor. Its drugs in development also include Ozarelix a luteinizing hormone releasing hormone antagonist, which is in Phase II clinical stage; SPI-1620, a peptide agonist of endothelin B receptors, which is in Phase I clinical stage; and RenaZorb, a lanthanum-based nanoparticle phosphate binding agent, which is in preclinical stage. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is based in Henderson, Nevada.
Advisors' Opinion:- [By Keith Speights]
Another prime case study for this comes from Spectrum Pharmaceuticals (NASDAQ: SPPI ) . Spectrum's stock more than doubled from October 2011 through July 2012. However, shares plunged 55% from those highs because business dynamics changed since then. A shortage of a generic rival to Spectrum's lead drug Fusilev was alleviated, resulting in sales slowing down considerably.�
- [By Keith Speights]
Biotech stocks are highly volatile. A good example of this is Spectrum Pharmaceuticals (NASDAQ: SPPI ) . Spectrum rode a wave of generic leucovorin shortages in late 2010 and early 2011 to stock gains of more than 170%. Shares then plunged more than 30% from July through September 2011. But the ride wasn't over yet.
10 Best Heal Care Stocks To Buy Right Now: Airbus Group NV (EADSF)
Airbus Group NV, known as European Aeronautic Defence and Space Company EADS NV, is a Netherlands-based company active within the aerospace and defense sector. The Company manufactures aircrafts, helicopters, commercial space launch vehicles, missiles, satellites, defense systems and defense electronics, and offers services related to these activities. The Company oprates four divisions. The Airbus division comprises the Airbus Commercial and Airbus Military segments, which develop, manufacture, market and sell commercial jet aircrafts, military transport aircrafts and special mission aircrafts, among others. The Eurocopter division develops, markets and sells civil and military helicopters. The Astrium division develops, manufactures and sells satellites, orbital infrastructures and launchers, as well as provides space-related services. The Cassidian division develops, manufactures and sells missiles systems, military combat and training aircrafts, among others. Advisors' Opinion:- [By Alanna Petroff]
Last month, Airbus, which is owned by the European aerospace group EADS (EADSF), predicted the number of aircraft worldwide would double over the next 20 years, spurred by rising demand from emerging markets.
10 Best Heal Care Stocks To Buy Right Now: Wajax Corp (WJX)
Wajax Corporation (Wajax), is engaged in the sale and after-sales parts and service support of equipment, power systems and industrial components. Wajax�� three business divisions include equipment,power systems and industrial components. Its equipment division is engaged in the distribution, rental, modification and servicing of mobile equipment from manufacturers. It Power Systems is engaged in the distribution, rental and servicing of engines, transmissions and generators for on-highway, off-highway and electric power generation applications. Industrial components is engaged in the distribution, servicing, custom design and assembly of industrial components for in-plant customers and original equipment manufacturers. The Company�� products include excavators, lift trucks, mining trucks and shovels, forest harvesting equipment, utility equipment, loader backhoes, container handlers, cranes, diesel and natural gas engines, transmissions and power generators and bearings. Advisors' Opinion:- [By John Heinzl]
For example, BMO Nesbitt Burns analyst Bert Powell recently raised his price target on Wajax (WJX) to $41.50 from $35.50 because, as he explained in a note, he believes the company is poised for a recovery. The new target reflects his expectation that the stock will trade at 11 times his 2015 earnings per share estimate of $3.77��ts average P/E multiple historically.
10 Best Heal Care Stocks To Buy Right Now: Durect Corporation(DRRX)
DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical products and therapies based on its proprietary drug formulations and delivery platform technologies. The company sells ALZET osmotic pumps for animal research use; LACTEL biodegradable polymers, which are used as raw materials in pharmaceutical and medical products; and excipients for pharmaceutical and medical device clients for use as raw materials in their products. Its product pipeline consists of Remoxy, an oral oxycodone gelatin capsule for the treatment of chronic pain under approval stage with the U.S. Food and Drug Administration; POSIDUR, a Phase III clinical stage sustained-release formulation of bupivacaine for the treatment of post-surgical pain; ELADUR, a Phase II clinical stage transdermal bupivacaine patch intended to provide continuous delivery of bupivacaine for up to three days from a single application for pain; and TRANSDUR, a Phase II clinical stage transdermal sufentanil patch intended to provide continuous delivery of sufentanil for up to seven days from a single application for chronic pain. The company?s Phase II clinical stage products comprise ORADUR-based opioid for the treatment of pain; and ORADUR-ADHD for the treatment of attention deficit hyperactivity disorder. It also conducts various research programs covering diseases and medical conditions of the central nervous system, cardiovascular disease, and cancer. The company has strategic agreement with Hospira, Inc.; Alpharma Ireland Limited; Nycomed Danmark ApS; Pain Therapeutics, Inc.; Pfizer Inc; Endo Pharmaceuticals Inc.; and EpiCept Corporation. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 name that's starting to move within range of triggering a major breakout trade is Durect (DRRX), which develops pharmaceutical products based on its proprietary drug delivery technology platforms. This stock is off to a hot start in 2013, with shares up sharply by 41%.
If you take a look at the chart for Durect, you'll notice that this stock has been trending sideways for the last two months and change, with shares moving between $1 on the downside and $1.34 on the upside. Shares of DRRX have now started to flirt with that $1.34 major resistance level on Thursday, since the stock has hit an intraday high of $1.35 a share with strong upside volume flows. This could be signaling that shares of DRRX are ready to break out above the upper-end of its recent range and trend substantially higher.
Traders should now look for long-biased trades in DRRX if it manages to break out above some near-term overhead resistance levels at $1.34 to $1.35 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 679,480 shares. If that breakout triggers soon, then DRRX will set up to re-fill some of its previous gap down zone from May that started near $1.80 a share. If DRRX gets into that gap with volume, then this stock could easily trend north of $2 a share.
Traders can look to buy DRRX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at its 50-day moving average of $1.16 a share or its 200-day moving average at $1.11 a share. One can also buy DRRX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
No comments:
Post a Comment